
What happens when a rare disease drug seems to work, but the health care system doesn’t?

Orphan Disease Center 2024 Million Dollar Bike Ride Grants - $139,416 for STXBP1 Research Awarded

STXBP1 Foundation Accelerates Growth with Addition of New Executive Director

STXBP1 Census - Q4 2024

Capsida Biotherapeutics granted orphan drug designation for potential gene therapy for STXBP1-related disorders

FDA Grants Orphan Drug Designation to Capsida Biotherapeutics for Potential Treatment of STXBP1 Developmental and Epileptic Encephalopathy

Advancing Toward Gene Therapies for Rare Epilepsies

Newly Published “Voice of the Patient Report”

STXBP1 Census - Q3 2024
